BioPharma, Pharma BioNTech Pact and Stock Sale Infuse Autolus With $600M for Its Cell Therapies By Frank Vinluan
BioPharma, Pharma With FDA nod, ChemoCentryx pill stands out in a sea of injectable & infused meds By Frank Vinluan
BioPharma, Pharma Amicus deal puts it on path to profitability, infuses its gene therapies with $400M By Frank Vinluan
BioPharma Vertex, CRISPR Therapeutics infuse first patient in CRISPR/Cas9-based gene therapy study By Alaric DeArment
Startups, BioPharma Private equity firm Cerberus infuses $105M into vaccine maker PaxVax By Meghana Keshavan
Top Story Case against Medtronic’s Infuse bone-growth device now potentially headed to the Supreme Court By Nicole Oran
Daily A 3D printed, keratin-infused burn dressing: North Carolina startup gets $1.7M By Meghana Keshavan
Devices & Diagnostics Medtronic is on the defensive again with InFuse. Will the Yale review redeem it? By Arundhati Parmar
Devices & Diagnostics DOJ closes investigation of Medtronic’s controversial product Infuse By Arundhati Parmar
Devices & Diagnostics Medtronic to pay $85M to settle Infuse-related class action lawsuit By Arundhati Parmar
Devices & Diagnostics Who can win the race to substitute Medtronic’s Infuse bone graft product? By Arundhati Parmar
Devices & Diagnostics What is the future of Medtronic’s controversial spinal fusion product Infuse? By Arundhati Parmar
